NATALIE PAEZ: Open Payments
NPI 1437812880 · NORTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 11 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $299 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $82 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Lilly USA, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| TerSera Therapeutics LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $19 |
Products named: Enhertu, VERZENIO, KISQALI, Zoladex, KEYTRUDA, MYRISK.
Industry payments across FL — which companies pay providers there.
